Studies on the absorption and excretion of tripotassium dicitrato-bismuthate in man.
In 8 volunteers blood and urine bismuth levels were detected after a 5-day course of tripotassium dicitrato-bismuthate and rose further with increasing dose. In 24 patients, blood and urine bismuth were measured on the last day of treatment. There was no significant difference (p greater than 0.2) in either blood or urine bismuth levels amongst patients treated for 4,5 or 6 weeks with colloidal bismuth. None of the blood level measurements exceeded 50 micrograms/l. Bismuth was slowly eliminated in the urine after stopping treatment.
D000328:Adult; D000897:Anti-Ulcer Agents / Q000378:metabolism*; D001729:Bismuth / Q000378:metabolism* / Q000652:urine; D005260:Female; D006801:Humans; D007408:Intestinal Absorption; D008297:Male; D008875:Middle Aged; D009942:Organometallic Compounds
D000897:Anti-Ulcer Agents; D009942:Organometallic Compounds; C002791:bismuth tripotassium dicitrate; D001729:Bismuth